Skip to Content


Importer of Controlled Substances Registration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Notice of registration.


Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

End Preamble Start Supplemental Information


The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

CompanyFR docketPublished
Rhodes Technologies81 FR 46956July 19, 2016.
Bellwyck Clinical Services81 FR 54603August 16, 2016.
Cerilliant Corporation81 FR 57933August 24, 2016.
Noramco, Inc81 FR 57932August 24, 2016.
Cody Laboratories, Inc81 FR 54602August 16, 2016.
AMRI Rensselaer, Inc81 FR 54603August 16, 2016.
ALMAC Clinical Services Incorp (ACSI)81 FR 54602August 16, 2016.
Fresenius Kabi USA, LLC81 FR 54601August 16, 2016.
Akorn, Inc81 FR 57935August 24, 2016.
Actavis Laboratories FL, Inc81 FR 54602August 16, 2016.
Unither Manufacturing LLC81 FR 61250September 6, 2016.
Cambrex Charles City81 FR 63222September 14, 2016.
United States Pharmacopeial Convention81 FR 63220September 14, 2016.
R & D Systems, Inc81 FR 64509September 20, 2016.
Catalent CTS, LLC81 FR 66081September 26, 2016.

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons.

Start Signature

Dated: December 19, 2016.

Louis J. Milione,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2016-31273 Filed 12-27-16; 8:45 am]